4 курс / Акушерство и гинекология / Копылова_Ю_В_Роль_проангиогенных_и_антиангиогенных_факторов_в_развитии

//Российский медицинский журнал. - 2004. – №1. – С3-7.

51.Савельева, И.В. Беременность и метаболический синдром: состояние проблемы / И.В. Савельева // Российский вестник акушера-гинеколога. -2010—№2. -С.28-31.

52.Светлаков, А.В. Молекулярно-биологические аспекты имплантации у человека и животных / А.В. Светлаков, М.В. Яманова, А.Б. Егорова, С.В. Михуткина // Проблемы репродукции.

– 2002. -№ 2. – С.12-16.

53.Серов, В.Н. Плацентарная недостаточность / В.Н. Серов // Трудный пациент. - 2005. - т.З. - №2. - С.18-19.

54.Серов, В.Н. Критические состояния в акушерстве / В.Н. Серов, С.А. Маркин // Москва: Медиздат. - 2003. - 704с.

55.Сидельникова, В.М. Эндокринология беременности в норме и при патологии / В.М. Сидельникова // Москва: Медпресс-информ. - 2009. — 352с.

56.Сидорова, И.С. Внутриутробные инфекции / И.С. Сидорова, И.О. Макаров, Н.А. Матвиенко // Москва: МИА. - 2006. – 146с.

57.Сидорова, И.С. Иммуногистохимическая оценка распределения фактора роста эндотелия сосудов в плаценте, плацентарном ложе матки при нормальной беременности и у женщин с преэклампсией / И.С. Сидорова, А.П. Милованов, Е.И. Боровкова, А.Н. Солоницын

//Архив патологии. - 2008. - №1. – С. 12-17.

58.Смирнова, Т.Л. / Морфология плаценты при плацентарной недостаточности Т.Л. Смирнова, Т.А. Алексеева, В.Е. Сергеева // Фундаментальные исследования. – 2009. -№S7. – С.62-63.

59.Соколов, Д.И. Васкулогенез и ангиогенез в развитии плаценты / Д.И. Соколов // Журнал акушерства и женских болезней. - 2007. -

№3. – С.15-18.

60. Соколян, А.В. Динамика ангиогенных факторов роста во время

беременности и в послеродовом периоде у беременных с

121

хронической венозной недостаточностью / А.В. Соколян, А.В.

Мурашко, Л.В. Кречетова и др. // Проблемы репродукции. - 2009. -

№2. – С.20-23.

61.Стрельцова, В.Л. Оценка уровня здоровья женщин во время беременности с синдромом задержки роста плода с позиций теории адаптационных реакций организма / В.Л. Стрельцова // Дальневосточный медицинский журнал. – 2010. - №4. – С. 40-42.

62.Стрижаков, А.Н. Физиология и патология плода / А.Н. Стрижаков, А.И. Давыдов, Л.Д. Белоцерковцева, И.В. Игнатко // Москва: Медицина. - 2004. — 356с.

63.Стрижаков, А.Н. Системные нарушения гемодинамики при синдроме задержки роста плода как фактор риска гипоксически-

ишемических поражений ЦНС и отклонений психомоторного развития детей / А.Н. Стрижаков, З.М. Мусаев, Т.Ф. Тимохина, Б.И. Наумчик, А.В. Буданцева // Акушерство и гинекология. –

2003. - №1. – С.6–11.

64.Стрижаков, А.Н. Фетоплацентарная недостаточность: патогенез, диагностика, лечение / А.Н. Стрижаков, Т.Ф. Тимохина, О.Р. Баев // Вопросы гинекологии, акушерства и перинатологии. — 2003. —

№ 2 - с.53 — 64.

65.Стрижаков, А.Н. Синдром задержки роста плода / А.Н. Стрижаков, И.В. Игнатко, Е.В. Тимохина, Л.Д. Белоцерковцева // Москва: Геотар-Медиа. - 2012. – 120с.

66.Тришкин, А.Г. Тактика ведения беременных с задержкой роста плода / А.Г. Тришкин, Н.В. Артымук, Е.С. Бикметова // Доктор.Ру.- 2012. - № 7 (75). -С. 69-73.

67.Тютюнник, В.Л. Тактика ведения беременных при плацентарной недостаточности инфекционного генеза / В.Л. Тютюнник // Русский медицинский Журнал. – 2006. - №14. – С. 7-10.

68.Филиппов, О.С. Состояние здоровья женщин и основные

122

направления развития службы родовспоможения в Российской Федерации / О.С. Филиппов, Е.В. Гусева, В.И. Широкова //

Здравоохранение. - 2009.-N 11.- С.25-31.

69. Ali, KZ Effects of Radix et Rhizoma Rhodiolae Kirilowii on expressions of von Willebrand / KZ Ali, GJ Burton, ME Khalid, R. Moosa // J Obstet Gynecol Reprod Biol. - 2010. – P.128-133.

70.Amato, N.A. Placental insufficiency and intrauterine growth retardation / N.A. Amato, G. Maruotti, G. Scillitani et al. // Minerva Ginecol. 2007. - Vol. 59, N 4.-P 357-367.

71.Bates, DO. Glomerular filtration barrier and molecular segregation: guilty as charged? /DO Bates // J Am Soc Nephrol. - 2010. - №12. - P.11-20.

72.Bergers, G. Tumorigenesis and the angiogenic switch / G. Bergers, LE Benjamin LE // Nat. Rev. Cancer. - 2003 - N3(6) - P.401-410.

73.Buhimschi, CS. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia / CS Buhimschi, ER Norwitz, E Funai, S Richman, S Guller, CJ Lockwood, IA Buhimschi // Am J Obstet Gynecol. - 2005. - N 192. – P.734741.

74.Burton, G.I. Regulation of vascular growth and function in the human placenta / G.I. Burton, D.S. Charnock-Jones, E. Jauniaux // Reproduction. – 2009. – Vol. 138. – P.895 – 902.

75.Callen, P.W. Ultrasonography in obstetrics and gynecology / P.W. Callen // WB Saunders company. - 2000. – 1078p.

76.Cetin, I. The role of the placenta in intrauterine growth restriction (lUGR) / I Cetin, P. Antonazzo / Geburtshilfe Neonatol. – 2009. - N213(3). – P.84-88.

77.Chaiworapongsa, T. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age / T. Chaiworapongsa, R. Romero, F. Gotsch, J. Espinoza at al. // J Matem Fetal Neonatal Med. - 2008. - N21(l). – P.41-52.

123

78.Choksy, S. VEGF and VEGF receptor expression ... circulation? / S. Choksy, A. Pockley, Y. Wajeh, E. Chan // Eur J Vasc Endovasc Surg. - 2004. - N28. – P. 9—23.

79.Crispi, F. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction / F. Crispi,

C.Dominguez, E. Llurba, P. Martm-Gallan, L. Cabero, E. Gratacos // Am J Obstet Gynecol. – 2006. - N 195( 1 ). - 201 -207.

80.Crispi, F. Predictive value of angiogenic factors and uterine artery Doppler for earlyversus late-onset pre-eclampsia and intrauterine growth restriction / F. Crispi, C. Dominguez, E. Llurba, P. MartmGallan, L. Cabero, E. Gratacos // Ultrasound Obstet Gynecol. - 2008. N3. – P.303-309.

81.Collinson, D. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? / D. Collinson, R. Donnelly // Eur J Vasc Endovasc Surg. - 2004. - N28. - P.9–23.

82.Del Rio, M. Prenatal diagnosis of a right ventricular diverticulum complicated by pericardial effusion in the first trimester / M. Del Rio, JM Martinez, M. Bennasar, M. Palacio, F. Figueras, B. Puerto et al. // Ultrasound Obstet Gynecol. – 2005. - N25. – P.409-411.

83.Demir, R. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: Differences between placental vasculogenesis and angiogenesis / R. Demir, UA. Kayisli, Y. Seval et al // PLACENTA. – 2004. – N 25 (6). – P. 560-572.

84.Dhara, S. Immunohistochemical localization of insulin-like growth factors I and II at the primary implantation site in the Rhesus monkey /

S.Dhara, P.G.L. Lalitkumar, J. Sengupta, D. Ghosh // Mol. Hum. Reprod. - 2001. – N7. – P.365-371.

85.Diab, A.E. Angiogenic factors for the prediction of pre-eclampsia in

124

women with abnormal midtrimester uterine artery Doppler velocimetiy / A.E. Diab, M.M. El-Behery, M.A. Ebrahiem, A.E. Shehata // Int. J Gynaecol. Obstet. – 2008. – N.102(2). – P.146-51.

86.Dias, S. VEGF(165) promotes survival of leukemic cells by Hsp90mediated induction of Bcl-2 expression and apoptosis inhibition / S. Dias, S.V. Shmelkov, G. Lam, S. Rafii //Blood. – 2002. – Vol. 99, N7. - P. 2532-40.

87.Emanueli, C. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia / C. Emanueli, A. Minasi, A. Zacheo, J. Chao, L. Chao, MB Salis, S. Straino et al. // Circulation. - 2001. – Vol.103, N1. - P.125–132.

88.Erez, O. The change in concentrations of angiogenic and antiangiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for- gestational age / O. Erez, R. Romero, J Espinoza, Fu W, D. Todem, J.P. Kusanovic, F. Gotsch at al. // J Matem Fetal Neonatal Med. – 2008. - N21(5). P.279-287.

89.Ertan, A.K. Placental morphometry in pregnancies with reversed enddiastolic flow in the umbilical artery or fetal aorta / A.K. Ertan, He

J.P., U. Weickert et al. // Z Geburtshilfe Neonatol. – 2003. Vol. 207,

№5. – P. 173-178.

90.Forbes, K. Maternal growth factor regulation of placental development and fetal growth / K. Forbes, M. Westwood // Journal of Endocrinology.

-2010. – Vol.207, N 1.- P16.

91.Geva, E. Human placental vascular development: vasculogenic and angiogenic transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 / E. Geva, D.G. Ginzinger, CJ. Zaloudek, DH. Moore, A. Byrne et al // J Clin Endocrinol Metab. 2002. - N 87. – P. 4213–4224.

92.Hertig, A. Maternal serum sFlt-1 concentration is an early and reliable

125

predictive marker of preeclampsia / A. Hertig, N. Berkane, G. Lefevre et al. // Clin Chem. – 2004. - N50. P.170-177.

93. Hicklin, DJ. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis / DJ Hicklin, Ellis LM. J Clin Oncol. – 2005. – Vol.23, N5. – P.1011-1027.

94. Hoffmann, P. Role of EG-VEGF in human placentation: Physiological and pathological implications / P. Hoffmann, Y. Saoudi, M. Benharouga, CH. Graham, JP. Schaal, C. Mazouni, JJ Feige, N. Alfaidy // J Cell Mol Med. - 2009. -N13. – P. 2224-2235.

95.Kaufmann, R. Ruin theory revisited: stochastic models for operational risk / R. Kaufmann, G. Samorodnitsky // USA. - 2004.

96.Kim, YN. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia / YN. Kim, DS Lee, DH Jeong, MS Sung, KT Kim // Prenat. Diagn. – 2009.- Vol. 29, N5. - P.464-470.

97.Krauss, T. Prospective analysis of placenta growth factor (P1GF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia / T. Krauss, HU. Pauer, HO. Augustin // Hypertens Pregnancy. - 2004. Vol.23. – Nl. -P101- 11.

98.Laskowska, M. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine fetal growth retardation? Preliminary communication / M. Laskowska, K. Laskowska, B. Leszczynska-

Gorzelak, J. Oleszczuk // Med Wieku Rozwoj. - 2008. - N12(1). –

P.499-506.

99.Levine, RJ. Circulating angiogenic factors and the risk of preeclampsia. RJ Levine, SE Maynard, C. Qian, Lim KH, LG. England, Yu K.F, EF. Schisterman, R. Thadhani, BP. Sachs at al. // N Engl J Med. – 2004.- P. 672-683.

100.Machaalani, R. Vascular endothelial growth factor receptor 1 (Fltl)

126

and apoptosis in the preeclamptic placenta and effects of in vivo antihypertensive exposure / R. Machaalani, A. Makris, C. Thornton, A. Hennessy // Hypertens Pregnancy.- 2008. - N27(4). P.361-373.

101.Maynard, SE. Excess placental soluble fms-like tyrosine kinase 1 (sFltl) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia / SE. Maynard, J.Y. Min, J. Merchan et al. // J Clin Invest 2003. - N 111. – P.649-658.

102.Malamitsi-Puchner, A. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates / A. Malamitsi-Puchner, T. Boutsikou, E. Economou, A. Sarandakou, E. Makrakis, D. Hassiakos, G. Creatsas // Mediators Inflamm. – 2005. -N24. – P.293-297.

103.Mandruzzato, G.P. Intrauterine growth restriction (IUGR): guidelines for definition, recognition and management / G.P. Mandruzzato // Archives of Perinatal Medicine. – 2008.- Vol. 14, p. 7–8.

104.Maulik, D. Fetal growth restriction: pathogenic mechanisms / D. Maulik, Frances Evans J, L. Ragolia // Clin Obstet Gynecol. -2006. - N49(2). – P.219-227.

105.Mitra, SC. Placental vessel morphometry in growth retardation and increased resistance of the umbilical artery Doppler flow / SC. Mitra, S.V. Seshan, L.E. Riachi // J Matern Fetal Med. – 2000. - N9(5). –

P.282-6.

106.Muetze, S. Mutation analysis of the growth factor genes P1GF, Fltl, IGF-I, and IGF-IR in intrauterine growth restriction with abnormal placental blood flow / S. Muetze, A. Kapagerof, L. Vlachopoulos, T. Eggermann, P. Kaufmann, K. Zerres, W. Rath, S. Rudnik-Schoenebom // J Matem Fetal Neonatal Med. – 2009. - N30. – P.1-6.

107.Nevo, O. Placental expression of sFlt-1 is increased in singletons and twin pregnancies with intrauterine growth restriction / O. Nevo, A. Many, J. Xu, J. Kingdom, E. Piccoli, S. Zamudio, M. Post et.al // J Clin

127

Endocrin Metab. - 2007. P. 23.

108.Parra, M. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction / M. Parra, R. Rodrigo, P. Barja et al. // Am J Obstet Gynecol. - 2005. – N.193. – P.:1486-1491.

109.Plaisier, M. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions / M. Plaisier, I. Dennert, E. Rost et al. // Hum. Reprod. – 2009.

–Vol. 24. – P.185–197.

110.Poon, LC. Maternal serum placental growth factor (P1GF) in small for gestational age pregnancy at 11 (+0) to 13(+6) weeks of gestation / L.C. Poon , E. Zaragoza, R. Akolekar, E. Anagnostopoulos, KH. Nicolaides // Prenat Diagn. - 2008. -N28(12). – P.110-115.

111.Rampello, S. Transabdominal uterine arteries Doppler at 12-14th and 20-24th week of gestation and pregnancy outcome: A prospective study / S. Rampello, L. Frigerio, E. Ricci, E. Rota, M. Lucianetti, F. Parazzini // Eur J Obstet Gynecol Reprod Biol. - 2009. – N. 26. – P.110-117.

112.Randhawa, RS. The insulin-like growth factor system and fetal growth restriction / R.S. Randhawa // Pediatr Endocrinol Rev. – 2008.- N6(2). – P.235-240.

113.Redman, CW. Latest advances in understanding preeclampsia / CW. Redman, I. Sargent // Science. – 2005.N308. P.1592-1594.

114.Sattar, N. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? / N. Sattar, IA. Greer // Br Med J. – 2002. - P. 325.

115.Satu, H. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies / H. Satu, O. Carpen, C. Homig, H. Weich, E. Halmesmaki // Molecular Human Reproduction. -2001. - Vol. 7, N. 2. –P.205-210.

116.Semczuk-Sikora, A. Maternal serum concentration of angiogenic

128

factors: PIGF, VEGF and VEGFR-1 and placental volume in pregnancies complicated by intrauterine growth restriction / A. Semczuk-Sikora, A. Krzyzanowski, N. Stachowicz, J. Robak, J. Kraczkowski, M. Kwiatek, M. Semczuk // Ginekol Pol. - 2007. – N.78(10). –P.783-786.

117.Shamim Sheikh, Pumima Satoskar and Deepa Bhartiya Expression of insulinlike growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Diabetes, Obesity and Metabolism, Volume 3, Number 6, December 2001 , pp. 457-462(6)

118.Shingo Kajimura, Katsumi Aida, and Cunming Duan.Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. 2002 J. Endocrinol. 175,3-18.

119.Simmons LA, Hennessy A, Gillin AG, Jeremy RW: Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and preeclamptic pregnancy. BJOG 2000; 107:678-85

120.Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, Connor JM, Dobbie R.Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.Obstet Gynecol. 2007 Jun; 109(6): 1316-24.

121.Stepan H, Jank A. Angiogenic factors and their role in pathogenesis and prediction of preeclampsia. Z Geburtshilfe Neonatol. 2009 Jun;213(3):101-5. Epub 2009 Jun 17. German.

122.Stepan H., Unversucht A., Wessel N., Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007 Apr; 49 (4): 818-24.

123.Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M,

Sudhakar A, Kalluri R. Neutralization of circulating vascular

129

endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria // J Biol Chem. 2003 Apr 11;278(15):12605-8. Epub 2003 Jan 21.

124.Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy // Reproduction. 2002 Mar;123(3):379-87.

125.Szukiewicz D, Szewczyk G, Watroba M, Kurowska K, Maslinski S.Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy,Gynecol Obstet Invest. 2005;59(2): 102-7. Epub 2004 Dec 9.

126.Thakur A, Sase M, Lee JJ, Thakur V, Buchmiller TL. Ontogeny of insulin-like growth factor 1 in a rabbit model of growth retardation. J Surg Res. 2000 Jun l5;91(2):l35-40.

127.Timothy R. H. Regnault, Barbra de Vrijer, Henry L. Galan, Meredith L. Davidsen, Karen A. Trembler, Frederick C. Battaglia, Randall B. Wilkening and Russell V. Anthony. The relationship between transplacental O2 diffusion and placental expression of PIGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction. Physiol (2003), 550.2, pp. 641656.

128.Tjoa ML, Oudejans CB, van Vugt JM, Blankenstein MA, van Wijk I Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction. JHypertens Pregnancy. 2004;23(2): 171 -89. Review.

129.Toft JH, Lian IA, Tarca AL, Erez O, Espinoza J, Eide IP, Bjerge L, Draghici S, Romero R, Austgulen R.Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PIGF) in placentas from pre-eclamptic and small-for- gestational-age pregnancies.J Matem Fetal Neonatal Med. 2008 Apr;21(4):267-73.

130. Torry DS, Hinrichs M, Torry RJ.Determinants of placental

130